Trial Profile
Evaluation of the effect of letrozole on symptomatic uterine leiomyomas.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 30 Sep 2011 New trial record